ASTM F2211-02
Standard Classification for Tissue Engineered Medical Products (TEMPs)

Standard No.
ASTM F2211-02
Release Date
2002
Published By
American Society for Testing and Materials (ASTM)
Status
Replace By
ASTM F2211-04
Latest
ASTM F2211-13(2021)
Scope

1.1 This classification outlines the aspects of tissue engineered medical products that will be developed as standards. This classification excludes traditional transplantation of organs and tissues as well as transplantation of living cells alone as cellular therapies.

1.2 This classification does not apply to any medical products of human origin regulated by the U.S. Food and Drug Administration under 21 CDR Parts 16 and 1270 and 21 CFR Parts 207, 807, and 1271.

1.3 This standard does not purport to address specific components coverd in other standards. Any safety areas associated with the medical product's use will not be addressed in this standard.This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory requirements prior to use.

ASTM F2211-02 history

  • 2021 ASTM F2211-13(2021) Standard Classification for Tissue-Engineered Medical Products (TEMPs)
  • 2013 ASTM F2211-13 Standard Classification for Tissue Engineered Medical Products (TEMPs)
  • 2004 ASTM F2211-04 Standard Classification for Tissue Engineered Medical Products (TEMPs)
  • 2002 ASTM F2211-02 Standard Classification for Tissue Engineered Medical Products (TEMPs)



Copyright ©2024 All Rights Reserved